SEC Filing Analysis: Core Scientific, Inc.

Executive Summary

• Trading Significance: High
• Key Takeaway: Activist investor Two Seas Capital LP has increased its stake in Core Scientific, Inc. to 6.5% and formally stated its intention to vote against and solicit proxies to oppose a pending merger agreement. The firm made multiple open-market purchases, including acquiring 525,000 shares for approximately $8.97 million on October 7, 2025.
• Market Impact: This action is highly likely to increase stock volatility and trading volume. It signals a potential proxy fight, creating uncertainty around the merger's success and pitting a major shareholder against company management.

Company Information

Field	Value
Company	Core Scientific, Inc.
Ticker Symbol	Not provided in filing
CIK	0001839341
Industry	Finance Services [6199]

Insider Information

Field	Value
Name	Two Seas Capital LP (Reporting Group)
CIK	0001823138
Title/Position	Investment Advisor (Sina Toussi is CIO & Managing Member)
Relationship	10%+ Owner

Transaction Details

This Schedule 13D/A amendment details numerous transactions over the past 60 days. The most recent event date is October 7, 2025, which involved the following aggregate open-market purchases:

Field	Value
Form Type	SCHEDULE 13D/A
Transaction Date	2025-10-07
Transaction Code	P (Purchase)
Security Type	Common Stock, par value $0.00001 per share
Shares Involved	525,000
Avg. Price Per Share	~$17.08
Total Value	~$8,965,200
Shares Owned After	19,902,624 (by reporting group)
Ownership Type	Indirect

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral to Positive
• Reasoning: The activist's buying pressure and belief in higher standalone value could be seen as bullish. However, the risk of a failed merger and a costly proxy battle could introduce significant downward pressure. The net effect will depend on the market's perception of the merger's value versus the activist's plan.

Volume & Sentiment

• Expected Volume Impact: High. Proxy contests and activist campaigns typically attract significant arbitrageur and institutional interest, leading to elevated trading volumes.
• Sentiment Indicator: Bullish on standalone value, Bearish on merger arbitrage. Overall sentiment is likely to be mixed and highly volatile.

Investment Insights

Positive Market Indicators

• High-Conviction Buying: The reporting person is actively purchasing shares in the open market, demonstrating a strong belief in their thesis.
• Activist Intervention: An activist investor believes there is unlocked value, either by defeating the merger or forcing a higher price.
• Substantial Ownership: A 6.5% stake gives the activist significant influence over the company's strategic decisions.

Risk Factors

• Proxy Battle Risk: Proxy fights are expensive, distracting for management, and have uncertain outcomes.
• Merger Termination Risk: If the merger is terminated, the stock could fall, especially if a premium was priced in.
• Market Volatility: The stock is likely to experience significant price swings based on news and speculation regarding the proxy contest.

Key Takeaways

1. Activism is Live: Two Seas Capital is not a passive investor and is actively working to defeat the current merger proposal.
2. Significant Capital Deployed: The firm has invested a substantial amount, with an aggregate purchase price across its funds exceeding $180 million.
3. Ownership Crossroads: The filing puts Core Scientific at a strategic crossroads, with its future path to be determined by the outcome of the special meeting and potential proxy battle.

Contextual Analysis

Timing Significance

The filing is strategically timed ahead of the "upcoming Special Meeting" to vote on the merger. By filing a Definitive Proxy Statement on September 29, 2025, and amending their 13D now, the reporting persons are escalating their campaign to influence shareholder votes.

Transaction Context

The transactions are all open-market purchases, funded by the working capital of the various funds managed by Two Seas Capital. This is not a grant or pre-arranged transaction, but a deliberate accumulation of shares from the public market.

Company Context

Core Scientific, Inc. is in the midst of a major corporate action (a merger agreement). The emergence of a significant, vocal opponent to this deal is a material event that challenges the board's recommended course of action.

Risk Assessment

Risk Level: High

Risk Factors

• Binary Outcome: The stock's short-term performance is heavily tied to the binary outcome of the merger vote.
• Management Distraction: A proxy fight can divert management's attention from core business operations.
• Cost of Activism: Both the company and the activist will incur significant legal and advisory fees.

Market Considerations

• Arbitrage Spreads: The spread on the merger deal will likely widen, reflecting the increased risk of failure.
• Sector Sentiment: The event may draw broader market attention to the Finance Services / Crypto Assets sector.
• Institutional Positioning: Other large holders will now have to take a side, potentially leading to large block trades.

---

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-10 | Data source: SEC EDGAR